The influence of white-coat hypertension on left atrial phasic function

Marijana Tadic1,2, Cesare Cuspidi3, Biljana Pencic1,2

  • 1a Cardiology Department , University Clinical Hospital Center "Dr. Dragisa Misovic - Dedinje" , Belgrade , Serbia.

Blood Pressure
|September 8, 2016
PubMed

Insights

White-coat hypertension (WCH) significantly affects left atrial (LA) function and stiffness, even in individuals with normal 24-h blood pressure. Clinic systolic blood pressure is linked to LA remodeling in WCH patients.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Echocardiography

Background:

  • White-coat hypertension (WCH) is characterized by elevated clinic blood pressure (BP) but normal ambulatory BP.
  • Left atrial (LA) function is crucial for cardiac health and can be affected by hypertensive conditions.
  • Understanding the impact of WCH on LA function is important for early cardiovascular risk assessment.

Purpose of the Study:

  • To investigate the association between white-coat hypertension (WCH) and left atrial (LA) phasic function.
  • To assess LA volumetric and mechanical properties using echocardiography in normotensive, WCH, and hypertensive individuals.
  • To determine the relationship between clinic systolic BP and LA remodeling in the study population.

Main Methods:

  • Cross-sectional study involving 52 normotensive, 49 WCH, and 56 untreated hypertensive patients.
  • 24-hour ambulatory BP monitoring and two-dimensional echocardiography (2DE) including volumetric and speckle tracking analysis.
  • WCH diagnosis based on elevated clinic BP and normal 24-h BP.

Main Results:

  • LA volumes and volume indexes significantly increased from normotensive to WCH and hypertensive groups.
  • Passive LA emptying fraction (conduit function) decreased, while active LA emptying fraction (booster pump function) increased across these groups.
  • LA stiffness index progressively increased from normotensive to WCH and hypertensive subjects; clinic systolic BP correlated with LA functional and mechanical remodeling.

Conclusions:

  • White-coat hypertension significantly impacts left atrial phasic function and stiffness.
  • Clinic systolic blood pressure is associated with functional and mechanical left atrial remodeling in individuals with WCH.
  • These findings highlight the subclinical cardiovascular changes associated with WCH.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
849
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a...
3.8K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
618
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K